Rapa Therapeutics
PrivateLast Round
Grant
Oct 5, 2023
Total Funding Raised
$12.2M
Company Overview
Rapa Therapeutics is a clinical-stage biotechnology company that develops adoptive T cell immunotherapy products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rapa Therapeutics Comparables
Compare Rapa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WindMIL Therapeutics | 82% | |
| Cellenkos, Inc. | 80% | |
| RegCell, Inc. | 78% |
Rapa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 5, 2023 | ||||
| VC Round | May 25, 2023 | ||||
| Grant | Feb 28, 2022 |
Rapa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| NIH RADx | Grant |
| TEDCO | VC Round |
| ArgyleRoad | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 26, 2024
Grew 33% QoQ from 9 to 12 employees.
- Sep 21, 2024
Grew 160% QoQ from 5 to 13 employees.
Rapa Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rapa Therapeutics's valuation, stock price, and market status.
Is Rapa Therapeutics a public or private company?
Rapa Therapeutics is a private company.
What is the current stock price of Rapa Therapeutics?
Rapa Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Rapa Therapeutics worth (valuation)?
Valuation information for Rapa Therapeutics is not publicly available.
Can I buy Rapa Therapeutics stock?
Rapa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rapa Therapeutics's last funding round?
Rapa Therapeutics's most recent funding round was Grant on October 5, 2023.
Who are the main investors in Rapa Therapeutics?
Key investors in Rapa Therapeutics include TEDCO.
Will Rapa Therapeutics IPO soon?
No public IPO plans have been announced for Rapa Therapeutics.
How can I track Rapa Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rapa Therapeutics's secondary market activity and sign up for updates.